Although the E6 and E7 oncoproteins’ capacities to, respectively, bind and inactivate the TP53 and RB tumor suppressor pathways are fairly understood within the context of the hrHPV replicative cycle, their role in cervical malignant transformation is still unclear. This evidence concerns the gene TP53 and neoplasm.